EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Gemigliptin attenuates reducing sugar-induced oxidative damage in MC3T3-E1 osteoblasts and improves osteoblastic differentiation

Hyunji Sang, Jaewon Kim, Sung Kweon Cho, Kwang Sik Suh, Woon-Won Jung, Sang Youl Rhee

Life Cycle · 2023

DOI: 10.54724/lc.2023.e11 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Cycle, 2023. Verfasst von Hyunji Sang und 5 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: LG Life Sciences, Inc, South Korea.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • LG Life Sciences, Inc, South Korea

Zitieren

APA

Sang, H., Kim, J., Cho, S. K., Suh, K. S., Jung, W., & Rhee, S. Y. (2023). Gemigliptin attenuates reducing sugar-induced oxidative damage in MC3T3-E1 osteoblasts and improves osteoblastic differentiation. Life Cycle. https://doi.org/10.54724/lc.2023.e11

Vancouver

Sang H, Kim J, Cho SK, Suh KS, Jung W, Rhee SY. Gemigliptin attenuates reducing sugar-induced oxidative damage in MC3T3-E1 osteoblasts and improves osteoblastic differentiation. Life Cycle. 2023. doi:10.54724/lc.2023.e11

BibTeX
@article{Sang2023,
  author = {Sang, Hyunji and Kim, Jaewon and Cho, Sung Kweon and Suh, Kwang Sik and Jung, Woon-Won and Rhee, Sang Youl},
  title = {Gemigliptin attenuates reducing sugar-induced oxidative damage in MC3T3-E1 osteoblasts and improves osteoblastic differentiation},
  journal = {Life Cycle},
  year = {2023},
  doi = {10.54724/lc.2023.e11}
}
Kostenlos starten →